| Dr Brett A Barkimer, MD | |
|
W129n7055 Northfield Dr, Menomonee Falls, WI 53051-0537 | |
| (262) 253-2510 | |
| (262) 253-3399 |
| Full Name | Dr Brett A Barkimer |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 20 Years |
| Location | W129n7055 Northfield Dr, Menomonee Falls, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255540134 | NPI | - | NPPES |
| 1255540134 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 51103 (Wisconsin) | Secondary |
| 207R00000X | Internal Medicine | 51103-020 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Memorial Hospital | Menomonee falls, WI | Hospital |
| Froedtert Memorial Lutheran Hospital | Milwaukee, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Froedtert Andthe Medical College Of Wisconsin Community Physicians Inc | 3678760063 | 1040 |
News Archive
An upward revision of the blood pressure numbers used to identify risk of end-stage renal disease (ESRD) might actually help doctors provide better care for their patients, said the authors of a study in patients with chronic kidney disease.
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today its unaudited first quarter financial results for the period ended March 31, 2011.
The Kansas Bioscience Authority has taken bold action to significantly increase the amount of venture capital available to innovative Kansas bioscience businesses - and to lead the state's economic recovery - approving a commitment to invest $50 million in eight private venture capital funds. The KBA investments will create a powerful magnet for private capital investment from around the country in Kansas bioscience companies.
Keas, the health management leader, today announced the launch of Health Hub, the first Health Management platform for self-insured employers.
Genzyme Corporation today reported four-year follow-up data from its completed Phase 2 multiple sclerosis (MS) trial showing an estimated 71 percent of alemtuzumab treated patients remain free of clinically-active disease as much as three years after most patients received their last course of the investigational compound. The data were presented at the American Academy of Neurology annual meeting.
› Verified 8 days ago
| Entity Name | The Medical College Of Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699720086 PECOS PAC ID: 2668384371 Enrollment ID: O20031120000259 |
News Archive
An upward revision of the blood pressure numbers used to identify risk of end-stage renal disease (ESRD) might actually help doctors provide better care for their patients, said the authors of a study in patients with chronic kidney disease.
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today its unaudited first quarter financial results for the period ended March 31, 2011.
The Kansas Bioscience Authority has taken bold action to significantly increase the amount of venture capital available to innovative Kansas bioscience businesses - and to lead the state's economic recovery - approving a commitment to invest $50 million in eight private venture capital funds. The KBA investments will create a powerful magnet for private capital investment from around the country in Kansas bioscience companies.
Keas, the health management leader, today announced the launch of Health Hub, the first Health Management platform for self-insured employers.
Genzyme Corporation today reported four-year follow-up data from its completed Phase 2 multiple sclerosis (MS) trial showing an estimated 71 percent of alemtuzumab treated patients remain free of clinically-active disease as much as three years after most patients received their last course of the investigational compound. The data were presented at the American Academy of Neurology annual meeting.
› Verified 8 days ago
| Entity Name | Froedtert &the Medical College Of Wisconsin Community Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568787448 PECOS PAC ID: 3678760063 Enrollment ID: O20101210000699 |
News Archive
An upward revision of the blood pressure numbers used to identify risk of end-stage renal disease (ESRD) might actually help doctors provide better care for their patients, said the authors of a study in patients with chronic kidney disease.
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today its unaudited first quarter financial results for the period ended March 31, 2011.
The Kansas Bioscience Authority has taken bold action to significantly increase the amount of venture capital available to innovative Kansas bioscience businesses - and to lead the state's economic recovery - approving a commitment to invest $50 million in eight private venture capital funds. The KBA investments will create a powerful magnet for private capital investment from around the country in Kansas bioscience companies.
Keas, the health management leader, today announced the launch of Health Hub, the first Health Management platform for self-insured employers.
Genzyme Corporation today reported four-year follow-up data from its completed Phase 2 multiple sclerosis (MS) trial showing an estimated 71 percent of alemtuzumab treated patients remain free of clinically-active disease as much as three years after most patients received their last course of the investigational compound. The data were presented at the American Academy of Neurology annual meeting.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brett A Barkimer, MD W129n7055 Northfield Drive, Internal Medicine, Menomonee Fa;;s, WI 53051-0538 Ph: (262) 253-5400 | Dr Brett A Barkimer, MD W129n7055 Northfield Dr, Menomonee Falls, WI 53051-0537 Ph: (262) 253-2510 |
News Archive
An upward revision of the blood pressure numbers used to identify risk of end-stage renal disease (ESRD) might actually help doctors provide better care for their patients, said the authors of a study in patients with chronic kidney disease.
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today its unaudited first quarter financial results for the period ended March 31, 2011.
The Kansas Bioscience Authority has taken bold action to significantly increase the amount of venture capital available to innovative Kansas bioscience businesses - and to lead the state's economic recovery - approving a commitment to invest $50 million in eight private venture capital funds. The KBA investments will create a powerful magnet for private capital investment from around the country in Kansas bioscience companies.
Keas, the health management leader, today announced the launch of Health Hub, the first Health Management platform for self-insured employers.
Genzyme Corporation today reported four-year follow-up data from its completed Phase 2 multiple sclerosis (MS) trial showing an estimated 71 percent of alemtuzumab treated patients remain free of clinically-active disease as much as three years after most patients received their last course of the investigational compound. The data were presented at the American Academy of Neurology annual meeting.
› Verified 8 days ago
Melissa L Earnest, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: W180n7950 Town Hall Rd, Menomonee Falls, WI 53051 Phone: 262-255-2500 | |
Dr. Beth M Lalande, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: W129n7055 Northfield Dr, Endocrinology, Menomonee Falls, WI 53051 Phone: 262-253-7155 Fax: 262-253-3399 | |
Khaled Taha, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: W180n8085 Town Hall Rd, Menomonee Falls, WI 53051 Phone: 262-251-1000 | |
Manan Shirishkumar Shah, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: W180n8085 Town Hall Rd, Menomonee Falls, WI 53051 Phone: 262-251-1000 Fax: 262-257-2707 | |
Shaibal Mazumdar, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: N84w16889 Menomonee Ave, Menomonee Falls, WI 53051 Phone: 262-251-7500 Fax: 262-251-7128 | |
Dr. Drew Richard Hietpas, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: W180n8000 Town Hall Rd, Menomonee Falls, WI 53051 Phone: 414-405-7569 | |
Kiran Kashyap, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: W180n7950 Town Hall Rd, Menomonee Falls, WI 53051 Phone: 262-255-2500 |